Alere up 8% as ruling approaches on Abbott case

|About: Abbott Laboratories (ABT)|By:, SA News Editor

Alere (ALR +7.9%) spikes on more than double normal volume ahead of the expected ruling on its dispute with would-be acquirer Abbott (ABT -0.1%). Investors clearly expect good news for the point-of-care diagnostics firm. Abbott has been trying to back out of the $5.8B deal due to a range of problems and loss of value.

Source: Bloomberg

Previously: Alere up 3% as investors anticipate improved prospects for favorable outcome with Abbott based on ruling by judge in different case (March 24)